Financial Snapshot
Revenues
Revenues
Revenue YoY Change
Revenues
Concept | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $0.00 | $75.00K | $73.00K | $59.00K | $102.0K | $12.20M | $3.580M | $8.360M | $2.950M | $2.830M | $1.260M | $1.500M | $520.0K | $340.0K | $160.0K | $270.0K | $500.0K | $380.0K | $2.830M | $910.0K | $510.0K | $430.0K | $160.0K | $130.0K | $430.0K |
YoY Change | -100.0% | 2.74% | 23.73% | -42.16% | -99.16% | 240.75% | -57.18% | 183.39% | 4.24% | 124.6% | -16.0% | 188.46% | 52.94% | 112.5% | -40.74% | -46.0% | 31.58% | -86.57% | 210.99% | 78.43% | 18.6% | 168.75% | 23.08% | -69.77% |
Expenses
Cost Of Revenues
Gross Profit
Gross Profit Margin
Gross Profit
Concept | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $0.00 | $75.00K | $73.00K | $59.00K | $102.0K | $12.20M | $3.580M | $8.360M | $2.950M | $2.830M | $1.260M | $1.500M | $520.0K | $340.0K | $160.0K | $270.0K | $500.0K | $380.0K | $2.830M | $910.0K | $510.0K | $430.0K | $160.0K | $130.0K | $430.0K |
Cost Of Revenue | -$108.0K | $0.00 | $9.000K | $123.0K | -$190.0K | $440.0K | $350.0K | $200.0K | $100.0K | $30.00K | $180.0K | $30.00K | $120.0K | $30.00K | $40.00K | $70.00K | $100.0K | $90.00K | $370.0K | $0.00 | $0.00 | $120.0K | $310.0K | $390.0K | |
Gross Profit | $108.0K | $80.00K | $64.00K | -$64.00K | $290.0K | $11.43M | $3.230M | $8.150M | $2.850M | $2.790M | $1.080M | $1.470M | $400.0K | $310.0K | $120.0K | $200.0K | $400.0K | $290.0K | $2.470M | $510.0K | $430.0K | $50.00K | -$180.0K | $40.00K | |
Gross Profit Margin | 106.67% | 87.67% | -108.47% | 284.31% | 93.7% | 90.22% | 97.49% | 96.61% | 98.59% | 85.71% | 98.0% | 76.92% | 91.18% | 75.0% | 74.07% | 80.0% | 76.32% | 87.28% | 100.0% | 100.0% | 31.25% | -138.46% | 9.3% |
Selling, General & Admin Expense
Research & Development
Depreciation, Depletion & Amortization
SGA Expense to Gross Profit Ratio
R&D To Gross Profit Ratio
DDA To Gross Profit Ratio
Operating Expenses Total
Operating Profits/Loss
Operational Expenses
Concept | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General & Admin | $6.989M | $6.380M | $6.646M | $6.512M | $5.570M | $6.800M | $6.760M | $6.850M | $10.04M | $6.770M | $4.400M | $3.730M | $3.270M | $1.930M | $1.300M | $1.250M | $2.190M | $1.320M | $1.850M | $3.850M | $6.160M | $5.020M | $580.0K | $570.0K | $680.0K |
YoY Change | 9.55% | -4.0% | 2.06% | 16.91% | -18.09% | 0.59% | -1.31% | -31.77% | 48.3% | 53.86% | 17.96% | 14.07% | 69.43% | 48.46% | 4.0% | -42.92% | 65.91% | -28.65% | -51.95% | -37.5% | 22.71% | 765.52% | 1.75% | -16.18% | |
% of Gross Profit | 6471.3% | 7975.0% | 10384.38% | 1920.69% | 59.49% | 209.29% | 84.05% | 352.28% | 242.65% | 407.41% | 253.74% | 817.5% | 622.58% | 1083.33% | 625.0% | 547.5% | 455.17% | 74.9% | 1207.84% | 1167.44% | 1160.0% | 1700.0% | |||
Research & Development | $15.61M | $12.77M | $11.27M | $7.020M | $3.001M | $4.567M | $5.340M | $5.220M | $9.670M | $5.180M | $3.450M | $1.310M | $1.350M | $1.260M | $1.070M | $830.0K | $670.0K | $580.0K | $930.0K | $2.300M | |||||
YoY Change | 22.19% | 13.33% | 60.57% | 133.92% | -34.29% | -14.48% | 2.3% | -46.02% | 86.68% | 50.14% | 163.36% | -2.96% | 7.14% | 17.76% | 28.92% | 23.88% | 15.52% | -37.63% | -59.57% | ||||||
% of Gross Profit | 14452.78% | 15967.5% | 17612.5% | 1034.83% | 39.96% | 165.33% | 64.05% | 339.3% | 185.66% | 319.44% | 89.12% | 337.5% | 406.45% | 891.67% | 415.0% | 167.5% | 200.0% | 37.65% | |||||||
Depreciation & Amortization | $87.00K | $136.0K | $167.0K | $231.0K | $190.0K | $158.0K | $150.0K | $160.0K | $10.00K | $30.00K | $10.00K | $10.00K | $0.00 | $0.00 | $0.00 | ||||||||||
YoY Change | -36.03% | -18.56% | -27.71% | 21.58% | 20.25% | 5.33% | -6.25% | -66.67% | 200.0% | 0.0% | |||||||||||||||
% of Gross Profit | 80.56% | 170.0% | 260.94% | 65.52% | 1.38% | 4.64% | 1.96% | 0.93% | 2.04% | 2.5% | 3.23% | 0.0% | 0.0% | 0.0% | |||||||||||
Operating Expenses | $22.49M | $19.16M | $17.93M | $13.53M | $8.383M | $9.616M | $12.25M | $12.24M | $19.71M | $11.95M | $7.850M | $5.070M | $4.640M | $3.200M | $2.380M | $2.080M | $2.870M | $1.910M | $2.780M | $6.240M | $6.040M | $5.120M | $550.0K | $590.0K | $670.0K |
YoY Change | 17.4% | 6.86% | 32.48% | 61.42% | -12.82% | -21.5% | 0.08% | -37.9% | 64.94% | 52.23% | 54.83% | 9.27% | 45.0% | 34.45% | 14.42% | -27.53% | 50.26% | -31.29% | -55.45% | 3.31% | 17.97% | 830.91% | -6.78% | -11.94% | |
Operating Profit | -$22.49M | -$19.08M | -$17.85M | -$13.60M | -$8.281M | $2.583M | -$9.020M | -$4.090M | -$16.86M | -$9.160M | -$6.770M | -$3.600M | -$4.240M | -$2.890M | -$2.260M | -$1.880M | -$2.470M | -$1.620M | -$310.0K | -$5.530M | -$4.690M | -$500.0K | -$770.0K | -$630.0K | |
YoY Change | 17.87% | 6.87% | 31.32% | 64.18% | -420.6% | -128.64% | 120.54% | -75.74% | 84.06% | 35.3% | 88.06% | -15.09% | 46.71% | 27.88% | 20.21% | -23.89% | 52.47% | 422.58% | 17.91% | 838.0% | -35.06% | 22.22% |
Interest Expenses
Interest Expenses To Operating Income %
Other Expense/Income
Interest & Other Expense/Income
Concept | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Interest Expense | $904.0K | -$33.00K | -$32.00K | -$323.0K | $62.00K | $122.0K | $0.00 | -$200.0K | -$300.0K | $480.0K | -$100.0K | $1.560M | $0.00 | $60.00K | -$60.00K | $0.00 | -$10.00K | $40.00K | -$50.00K | -$10.00K | -$30.00K | -$100.0K | -$80.00K | -$60.00K | -$70.00K |
YoY Change | -2839.39% | 3.13% | -90.09% | -620.97% | -49.18% | -100.0% | -33.33% | -162.5% | -580.0% | -106.41% | -100.0% | -200.0% | -100.0% | -125.0% | -180.0% | 400.0% | -66.67% | -70.0% | 25.0% | 33.33% | -14.29% | ||||
% of Operating Profit | 4.72% | ||||||||||||||||||||||||
Other Income/Expense, Net | $739.0K | -$481.0K | -$354.0K | $37.00K | $7.000K | $26.00K | |||||||||||||||||||
YoY Change | -253.64% | 35.88% | -1056.76% | 428.57% | -73.08% |
Income/Loss
Pretax Income
Income Tax
Net Profits/Loss
Pretax Income YoY Change
Income Tax Rate
Net Profits/Loss YoY Change
Basic EPS
Net Income To Revenue Ratio
Pretax & Net Income
Concept | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pretax Income | -$21.04M | -$18.95M | -$17.37M | -$13.88M | -$299.0K | $169.0K | -$9.020M | -$4.290M | -$18.03M | -$9.570M | -$6.880M | -$3.580M | -$4.240M | -$3.490M | -$4.080M | -$1.880M | -$2.480M | -$1.580M | -$370.0K | -$5.340M | -$5.560M | -$4.790M | -$590.0K | -$830.0K | -$700.0K |
YoY Change | 10.99% | 9.12% | 25.12% | 4542.81% | -276.92% | -101.87% | 110.26% | -76.21% | 88.4% | 39.1% | 92.18% | -15.57% | 21.49% | -14.46% | 117.02% | -24.19% | 56.96% | 327.03% | -93.07% | -3.96% | 16.08% | 711.86% | -28.92% | 18.57% | |
Income Tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$420.0K | $0.00 | $0.00 | $0.00 | $0.00 | -$70.00K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
% Of Pretax Income | 0.0% | ||||||||||||||||||||||||
Net Earnings | -$21.75M | -$19.56M | -$18.21M | -$13.88M | -$8.274M | $2.609M | -$9.020M | -$4.290M | -$18.03M | -$9.570M | -$6.460M | -$3.580M | -$4.240M | -$3.490M | -$4.080M | -$1.820M | -$2.480M | -$2.160M | -$5.740M | -$10.67M | -$5.560M | -$4.790M | -$590.0K | -$830.0K | -$700.0K |
YoY Change | 11.19% | 7.44% | 31.16% | 67.78% | -417.13% | -128.92% | 110.26% | -76.21% | 88.4% | 48.14% | 80.45% | -15.57% | 21.49% | -14.46% | 124.18% | -26.61% | 14.81% | -62.37% | -46.2% | 91.91% | 16.08% | 711.86% | -28.92% | 18.57% | |
Net Earnings / Revenue | -26082.67% | -24942.47% | -23528.81% | -8111.76% | 21.39% | -251.96% | -51.32% | -611.19% | -338.16% | -512.7% | -238.67% | -815.38% | -1026.47% | -2550.0% | -674.07% | -496.0% | -568.42% | -202.83% | -1172.53% | -1090.2% | -1113.95% | -368.75% | -638.46% | -162.79% | |
Basic Earnings Per Share | -$5.51 | -$14.12 | -$2.23 | -$3.23 | |||||||||||||||||||||
Diluted Earnings Per Share | -$5.51 | -$14.12 | -$2.23 | -$3.232M | -$8.108M | $17.10K | -$64.29K | -$24.22K | -$125.5K | -$82.06K | -$70.76K | -$85.06K | -$110.6K | -$166.5K | -$213.4K | -$118.3K | -$171.3K | -$202.6K | -$700.9K | -$1.933M | -$1.444M | -$1.447M | -$102.8K | -$136.7K | -$184.2K |
Assets & Liabilities
Cash & Short-Term Investments
Cash & Equivalents
Cash To Operating Expenses Ratio
Inventory
Receivables
Total Short-Term Assets
Property, Plant And Equipment
Long-Term Investments
Total Long-Term Assets
Total Assets
Net Income To Total Assets Percentage
Accounts Payable
Short-Term Debt
Long Term Debt Due
Total Short-Term Liabilities
Long-Term Debt
Other Long-Term Liabilities
Total Long-Term Liabilities
Total Liabilities
Short-Term To Long-Term Debt Ratio
Short-Term Assets To Debt Ratio
Long-Term Debt To Net Income Ratio
Assets & Liabilities
Concept | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Short-Term Investments | $2.480M | $4.062M | $19.77M | $9.800M | $15.86M | $12.00M | $13.43M | $13.58M | $16.78M | $29.57M | $1.450M | $3.150M | $7.130M | $550.0K | $1.510M | $1.770M | $4.210M | $670.0K | $4.630M | $3.290M | $140.0K | $960.0K | $0.00 | $10.00K | |
YoY Change | -38.95% | -79.45% | 101.72% | -38.21% | 32.17% | -10.65% | -1.1% | -19.07% | -43.25% | 1939.31% | -53.97% | -55.82% | 1196.36% | -63.58% | -14.69% | -57.96% | 528.36% | -85.53% | 40.73% | 2250.0% | -85.42% | -100.0% | |||
Cash & Equivalents | $2.480M | $4.062M | $0.00 | $4.570M | $15.73M | $11.91M | $13.35M | $13.58M | |||||||||||||||||
Short-Term Investments | $130.0K | $100.0K | $80.00K | $16.08M | $29.30M | $890.0K | $2.610M | $7.060M | $400.0K | $1.330M | $1.570M | ||||||||||||||
Other Short-Term Assets | $1.190M | $755.0K | $814.0K | $950.0K | $380.0K | $310.0K | $220.0K | $130.0K | $2.430M | $2.800M | $20.00K | $20.00K | $40.00K | $20.00K | $10.00K | $40.00K | $10.00K | $50.00K | $550.0K | $40.00K | $10.00K | $30.00K | $0.00 | ||
YoY Change | 57.62% | -7.25% | -14.32% | 150.0% | 22.58% | 40.91% | 69.23% | -94.65% | -13.21% | 13900.0% | 0.0% | -50.0% | 100.0% | 100.0% | -75.0% | 300.0% | -80.0% | -90.91% | 1275.0% | 300.0% | -66.67% | ||||
Inventory | $0.00 | $0.00 | $190.0K | $270.0K | $10.00K | ||||||||||||||||||||
Prepaid Expenses | |||||||||||||||||||||||||
Receivables | $60.00K | $3.000K | $25.00K | $60.00K | $2.540M | $3.150M | $3.390M | $730.0K | $110.0K | $100.0K | $130.0K | $160.0K | $290.0K | $90.00K | $110.0K | $210.0K | $980.0K | $80.00K | $30.00K | $60.00K | $30.00K | $10.00K | $730.0K | ||
Other Receivables | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $10.00K | $0.00 | ||
Total Short-Term Assets | $3.730M | $4.820M | $20.61M | $10.81M | $18.77M | $15.47M | $17.03M | $14.44M | $19.31M | $32.48M | $1.570M | $3.300M | $7.330M | $860.0K | $1.600M | $1.920M | $4.420M | $1.700M | $5.260M | $3.360M | $210.0K | $1.200M | $290.0K | $750.0K | |
YoY Change | -22.61% | -76.61% | 90.64% | -42.41% | 21.33% | -9.16% | 17.94% | -25.22% | -40.55% | 1968.79% | -52.42% | -54.98% | 752.33% | -46.25% | -16.67% | -56.56% | 160.0% | -67.68% | 56.55% | 1500.0% | -82.5% | 313.79% | -61.33% | ||
Property, Plant & Equipment | $610.0K | $993.0K | $577.0K | $770.0K | $470.0K | $240.0K | $340.0K | $380.0K | $350.0K | $40.00K | $30.00K | $30.00K | $30.00K | $10.00K | $10.00K | $10.00K | $10.00K | $0.00 | $680.0K | $220.0K | $140.0K | $240.0K | $150.0K | $260.0K | |
YoY Change | -38.57% | 72.1% | -25.06% | 63.83% | 95.83% | -29.41% | -10.53% | 8.57% | 775.0% | 33.33% | 0.0% | 0.0% | 200.0% | 0.0% | 0.0% | 0.0% | -100.0% | 209.09% | 57.14% | -41.67% | 60.0% | -42.31% | |||
Goodwill | |||||||||||||||||||||||||
YoY Change | |||||||||||||||||||||||||
Intangibles | |||||||||||||||||||||||||
YoY Change | |||||||||||||||||||||||||
Long-Term Investments | $10.00K | $10.00K | $90.00K | $50.00K | $0.00 | $0.00 | $0.00 | $0.00 | $510.0K | $0.00 | |||||||||||||||
YoY Change | 0.0% | -88.89% | 80.0% | -100.0% | |||||||||||||||||||||
Other Assets | $120.0K | $160.0K | $194.0K | $10.00K | $0.00 | $20.00K | $30.00K | $200.0K | $390.0K | ||||||||||||||||
YoY Change | -25.0% | -17.53% | 1840.0% | -100.0% | -33.33% | -85.0% | -48.72% | ||||||||||||||||||
Total Long-Term Assets | $730.0K | $1.153M | $771.0K | $780.0K | $480.0K | $330.0K | $390.0K | $380.0K | $350.0K | $50.00K | $30.00K | $30.00K | $30.00K | $10.00K | $10.00K | $10.00K | $10.00K | $0.00 | $680.0K | $15.45M | $9.440M | $8.500M | $930.0K | $720.0K | |
YoY Change | -36.69% | 49.55% | -1.15% | 62.5% | 45.45% | -15.38% | 2.63% | 8.57% | 600.0% | 66.67% | 0.0% | 0.0% | 200.0% | 0.0% | 0.0% | 0.0% | -100.0% | -95.6% | 63.67% | 11.06% | 813.98% | 29.17% | |||
Total Assets | $4.460M | $5.973M | $21.38M | $11.59M | $19.25M | $15.80M | $17.42M | $14.82M | $19.66M | $32.53M | $1.600M | $3.330M | $7.360M | $870.0K | $1.610M | $1.930M | $4.430M | $1.700M | $5.940M | $18.81M | $9.650M | $9.700M | $1.220M | $1.470M | |
YoY Change | |||||||||||||||||||||||||
Accounts Payable | $1.140M | $422.0K | $274.0K | $280.0K | $1.470M | $1.760M | $710.0K | $620.0K | $590.0K | $540.0K | $260.0K | $380.0K | $500.0K | $580.0K | $110.0K | $200.0K | $650.0K | $1.000M | $620.0K | $780.0K | $350.0K | $400.0K | $80.00K | $130.0K | |
YoY Change | 170.14% | 54.01% | -2.14% | -80.95% | -16.48% | 147.89% | 14.52% | 5.08% | 9.26% | 107.69% | -31.58% | -24.0% | -13.79% | 427.27% | -45.0% | -69.23% | -35.0% | 61.29% | -20.51% | 122.86% | -12.5% | 400.0% | -38.46% | ||
Accrued Expenses | $2.770M | $2.039M | $921.0K | $600.0K | $140.0K | $90.00K | $60.00K | $60.00K | |||||||||||||||||
YoY Change | 35.85% | 121.39% | 53.5% | 328.57% | 50.0% | 0.0% | |||||||||||||||||||
Deferred Revenue | |||||||||||||||||||||||||
YoY Change | |||||||||||||||||||||||||
Short-Term Debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $160.0K | $0.00 | $0.00 | $0.00 | $1.900M | $0.00 | $0.00 | $0.00 | |
YoY Change | -100.0% | -100.0% | |||||||||||||||||||||||
Long-Term Debt Due | $0.00 | $40.00K | $0.00 | $30.00K | $2.210M | $0.00 | $10.00K | $20.00K | |||||||||||||||||
YoY Change | -100.0% | -98.64% | -100.0% | -50.0% | |||||||||||||||||||||
Total Short-Term Liabilities | $3.980M | $2.532M | $1.369M | $1.140M | $2.640M | $1.890M | $860.0K | $770.0K | $1.260M | $900.0K | $1.010M | $600.0K | $1.280M | $810.0K | $400.0K | $640.0K | $1.340M | $1.650M | $2.730M | $1.900M | $5.000M | $690.0K | $700.0K | $1.070M | |
YoY Change | 57.19% | 84.95% | 20.09% | -56.82% | 39.68% | 119.77% | 11.69% | -38.89% | 40.0% | -10.89% | 68.33% | -53.13% | 58.02% | 102.5% | -37.5% | -52.24% | -18.79% | -39.56% | 43.68% | -62.0% | 624.64% | -1.43% | -34.58% | ||
Long-Term Debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $310.0K | $390.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $480.0K | $0.00 | $70.00K | |
YoY Change | -100.0% | -20.51% | -100.0% | -100.0% | |||||||||||||||||||||
Other Long-Term Liabilities | $280.0K | $559.0K | $0.00 | $210.0K | $0.00 | $40.00K | $30.00K | $10.00K | $0.00 | $180.0K | $260.0K | $280.0K | $0.00 | $0.00 | $0.00 | $0.00 | $10.00K | $10.00K | $50.00K | ||||||
YoY Change | -49.91% | -100.0% | -100.0% | 33.33% | 200.0% | -100.0% | -30.77% | -7.14% | -100.0% | 0.0% | -80.0% | ||||||||||||||
Total Long-Term Liabilities | $280.0K | $559.0K | $0.00 | $210.0K | $0.00 | $40.00K | $30.00K | $10.00K | $0.00 | $0.00 | $0.00 | $0.00 | $490.0K | $650.0K | $280.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $490.0K | $10.00K | $120.0K | |
YoY Change | -49.91% | -100.0% | -100.0% | 33.33% | 200.0% | -100.0% | -24.62% | 132.14% | -100.0% | 4800.0% | -91.67% | ||||||||||||||
Total Liabilities | $4.260M | $3.091M | $1.369M | $1.350M | $2.640M | $1.920M | $890.0K | $780.0K | $1.260M | $900.0K | $1.010M | $600.0K | $1.780M | $1.460M | $680.0K | $640.0K | $1.340M | $1.650M | $2.730M | $1.900M | $5.000M | $1.180M | $710.0K | $1.190M | |
YoY Change | 37.82% | 125.79% | 1.41% | -48.86% | 37.5% | 115.73% | 14.1% | -38.1% | 40.0% | -10.89% | 68.33% | -66.29% | 21.92% | 114.71% | 6.25% | -52.24% | -18.79% | -39.56% | 43.68% | -62.0% | 323.73% | 66.2% | -40.34% |
Ownership
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares
Stock Issuance & Repurchase
Ownership Data
Concept | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Basic Shares Outstanding | 4.060M | 1.386M | 8.172M | 4.295M | |||||||||||||||||||||
Diluted Shares Outstanding | 4.060M | 1.386M | 8.172M | 4.295M | |||||||||||||||||||||
Preferred Stock | |||||||||||||||||||||||||
Treasury Stock Shares |
Return On Shareholders' Equity
Book Value
Free Cash Flow
Free Cash Flow YoY
Free Cash Flow Margin
Dividends
Dividends
Stock Price
About Benitec Biopharma Inc.
Benitec Biopharma, Inc. is a development-stage biotechnology company, which engages in the advancement of novel genetic medicines. The company is headquartered in Hayward, California and currently employs 16 full-time employees. The company went IPO on 2012-07-11. The firm is focused on the advancement of novel genetic medicines. Its proprietary Silence and Replace deoxyribonucleic acid (DNA) -directed ribonucleic acid (RNA) interference platform combines RNA interference, or RNAi, with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The firm is developing Silence and Replace-based therapeutics (BB-301) for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy (OPMD). BB-301 is an adeno-associated viral vector (AAV)-based gene therapy designed to silence the expression of disease-causing genes (to slow, or halt, the underlying mechanism of disease progression) and to simultaneously replace the mutant genes with normal, wildtype genes.
Industry: Pharmaceutical Preparations Peers: Acorda Therapeutics, Inc. Cibus, Inc. Sonnet BioTherapeutics Holdings, Inc. Statera Biopharma, Inc. Ensysce Biosciences, Inc. EXICURE, INC. Xenetic Biosciences, Inc. NAVIDEA BIOPHARMACEUTICALS, INC. Phio Pharmaceuticals Corp.